| Metric / Component | Grade | Score (0–100) | Evidence | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | C+ | 38 | Extreme volatility (β=4.63), massive YTD recovery (+243%), sharp intraday drawdown (-14.6%), opaque fundamentals constrain conviction. | 6–12M |
| SA Quality/Value Composite | D | 28 | P/E, EPS, market cap, revenue all unavailable. No visibility on balance sheet, profitability, or growth trajectory. | Ongoing |
| Zacks Earnings Momentum | D– | 22 | Earnings date unknown; no forward guidance disclosed. Unable to assess near-term catalyst quality. | 1–3M |
| Institutional & Smart Money Flow | B– | 62 | 52W return +243% suggests retail/momentum appeal; however, extreme beta (4.63) and recent -14.6% intraday shock indicate thin liquidity and potential institutional de-risking. | 1–3M |
| Growth Sustainability & Moat | D+ | 32 | No sector, industry, revenue growth, or EPS growth data disclosed. Unable to assess competitive positioning or revenue durability. | 6–12M |
| Valuation & Safety (Pre-Penalty) | C– | 44 | Price recovery from $1.36 (52W low) to $12.08 (+789%) on zero disclosed fundamentals. No fair value anchor available. Risk/reward asymmetrically tilted to downside absent earnings inflection. | 6–12M |
| Penalty Overlay (Volatility, Opacity, Liquidity) | –16 points | Applied | Beta 4.63 (99th percentile volatility); critical data gaps (earnings, profile, P/E, market cap, volume); 52W range $1.36–$63.99 suggests speculative micro-cap behavior. | 1–6M |
| CONFIDENCE SCORE | C+ | 34 | Only 4 of 18 core metrics available (price, beta, 52W return, avg volume). Data coverage <25%. High model risk. | Ongoing |
| Volatility & Drawdown Risk | F | 12 | Beta = 4.63 (4.6× market risk); intraday range $11.65–$14.82 within single session; 52W drawdown from $63.99 to $1.36 = –97.9%. Extreme tail risk. | 1–3M |
| Crowding Risk Flag | ELEVATED | 65 | +243% YTD return typical of crowded retail/momentum trades. Extreme beta and thin avg volume (30.36K shares) suggest rapid mean-reversion risk on any negative catalyst. | 1–3M |
KORU's extreme volatility (β=4.63) and speculative trading profile place it in the sub-$2B micro-cap equity space, typical of early-stage biotech, technology ventures, or shell vehicles. The +243% YTD return combined with a 52W trough of $1.36 and recent peak of $63.99 suggests momentum-driven retail participation rather than fundamental institution adoption. Without disclosed sector, industry, profitability, or revenue metrics, direct peer benchmarking is not feasible. However, the risk/return signature is consistent with pre-revenue or pre-commercial companies experiencing hype cycles. Comparable volatility profiles exist in early SPACs, micro-cap biotech, and deep-value or distressed equity turnarounds.
Immediate risk: continued volatility and possible earnings disappointment or guidance revision if/when disclosed. The -14.6% intraday shock indicates fragile momentum. Positive catalyst: earnings release with beat or favorable forward guidance could trigger short-covering and retail FOMO. However, tight average volume (30.36K) implies rapid price swings on modest order flow. Tactically, hold stops tight; avoid leverage.
Fundamental inflection point. Without visibility into revenue growth, profitability, or market size, reversion to fair value is likely unless company discloses strong YoY growth and achieves profitability or positive cash flow. The +243% YTD run-up appears disconnected from any disclosed operational progress, raising mean-reversion risk. If company remains a cash-burn micro-cap with dilution ahead, expect significant downside; if genuine revenue/profit inflection emerges, re-rating possible but not assured. Confidence in 6–12M outlook is low due to data opacity.
- Data Opacity: Missing P/E, EPS, market cap, revenue, sector, industry, dividend, earnings date, and company profile. Coverage <25%.
- Extreme Volatility: Beta 4.63; 52W range $1.36–$63.99 (–97.9% trough-to-peak); intraday swing $11.65–$14.82. Institutional-grade risk management difficult.
- Liquidity Constraints: Avg volume 30.36K shares suggests thin bid-ask and rapid slippage on large orders.
- Momentum Crowding: +243% YTD return likely attracts retail; mean-reversion risk elevated on any negative surprise.
- Earnings Gap: Earnings date unknown; if negative or delayed, re-rating sharp downside likely.
KORU scores C+ (38/100) due to extreme volatility (β=4.63), critical data gaps (earnings, fundamentals, market cap), and speculative momentum profile (+243% YTD). Without disclosed profitability, revenue growth, or sector visibility, fundamental fair value cannot be anchored. Recent -14.6% intraday shock signals crowding risk and thin liquidity. Tactically: Use tight stops; avoid leverage; await earnings release. Strategically: No conviction buy unless company discloses strong operational inflection (revenue/profit growth, expanded margins, reduced burn). Current risk/reward skewed to downside absent catalysts. Suitable only for high-risk-tolerance, short-term traders; unsuitable for core institutional portfolios.
KORU Stock Analysis & Forecast
Is KORU a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
KORU Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, KORU shows balanced risk-reward characteristics.
Should You Buy KORU Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in KORU.